Training and System Familiarization for FDA Personnel

This contract involves providing specialized hands-on training and operational familiarization for up to three FDA personnel on the Illumina MiSeq i100 system. The training will cover aspects such as system use, maintenance procedures, and data interpretation to ensure that FDA staff are proficient in operating and understanding this specific sequencing technology. The goal is to enhance the FDA team’s technical knowledge and operational capabilities with the equipment. The contract is a subcontract issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with relevant activities classified under the NAICS code 611430, which pertains to professional and management development training. The solicitation was initially posted on May 15, 2026, with a response deadline of May 22, 2026. Although specific location details for performance and contact information are not provided, the contract’s primary focus is to support FDA staff’s practical expertise with the Illumina system to aid in their regulatory and scientific missions.